These findings also showed that the hypomethylation of VEGFB, PLGF, PLCB1, and FATP4 might be the potential biomarkers and therapeutic targets for early interventions in diabetic patients with cardiovascular diseases. The gene discussed is SLC27A4; the disease is cardiovascular disorder.